Medtronic Buy rating: cardiovascular device leadership, FY2026 revenue +8.4%, and FY2027 7% growth guide. Click for more on ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Medtronic ((MDT)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its ...

The bellwether trial is testing allegations that the Minnesota-run company’s mesh products injured patients and were marketed with misleading safety claims.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The company is using machine learning to enhance its product offerings. One of Medtronic's most prominent AI offerings is its GI Genius endoscopy module, a computer-assisted detection system for ...

Medtronic may be the largest publically-traded pure-play medical device company in the world, but not even Big Blue is immune from the macroeconomic challenges the rest of the industry is facing. CEO ...

Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...

Medtronic (NYSE: MDT) posted first-quarter earnings (for the period ended on June 30) that exceeded the average of Wall Street estimates. The results were strong enough for the medical technologies ...